Decided

No. 17-1229

Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc., et al.

from the United States Court of Appeals for the Federal Circuit

See other cases from the Federal Circuit.

Docket Entries

JUDGMENT ISSUED.

Adjudged to be AFFIRMED. Thomas, J., delivered the opinion for a unanimous Court.

Argued. For petitioner: Kannon K. Shanmugam, Washington, D. C.; and Malcolm L. Stewart, Deputy Solicitor General, Department of Justice, Washington, D. C. (for United States, as amicus curiae.) For respondents: William M. Jay, Washington, D. C.

Reply of petitioner Helsinn Healthcare S.A. filed. (Distributed)

Record received from the U.S.C.A. Federal Circuit is electronic and located on PACER, with the exception of some confidential documents (1 Envelope).

CIRCULATED

Brief amicus curiae of Congresswoman Zoe Lofgren filed.

Brief amici curiae of SPCM S.A. and High Tech Inventors Alliance filed.

Brief amicus curiae of IEEE-USA filed.

Brief amicus curiae of Intel Corporation filed.

Brief amicus curiae of Association for Accessible Medicines filed.

Brief amici curiae of R Street Institute and Engine Advocacy filed.

Record requested from the U.S.C.A. Federal Circuit.

Brief amici curiae of 45 Intellectual Property Professors filed.

Motion of the Solicitor General for leave to participate in oral argument as amicus curiae and for divided argument GRANTED. Justice Kavanaugh took no part in the consideration or decision of this motion.

Brief of respondents Teva Pharmaceuticals USA, Inc., et al. filed.

SET FOR ARGUMENT on Tuesday, December 4, 2018

Motion of the Solicitor General for leave to participate in oral argument as amicus curiae and for divided argument filed.

Brief amicus curiae of Pharmaceutical Research and Manufacturers of America filed.

Brief amicus curiae of United States of America filed.

Brief amicus curiae of Intellectual Property Owners Association in support of neither party filed.

Motion to extend the time to file the briefs on the merits granted. The time to file the joint appendix and petitioner's brief on the merits is extended to and including August 23, 2018. The time to file respondents' brief on the merits is extended to and including October 9, 2018.

Motion for an extension of time to file the briefs on the merits filed.

Petition GRANTED.

DISTRIBUTED for Conference of 6/21/2018.

Reply of petitioner Helsinn Healthcare S.A. filed. (Distributed)

DISTRIBUTED for Conference of 6/14/2018.

Brief of respondents Teva Pharmaceuticals USA, Inc., et al. in opposition filed.

Brief amicus curiae of The Naples Roundtable filed.

Brief amicus curiae of The Massachusetts Biotechnology Council filed.

Brief amicus curiae of Bar Association of the District of Columbia filed.

Brief amicus curiae of US Inventor, Inc. filed.

Brief amicus curiae of The Biotechnology Innovation Organization (BIO) filed.

Brief amicus curiae of Boston Patent Law Association in support of neither party filed.

Brief amicus curiae of Pharmaceutical Research and Manufacturers of America filed.

Brief amicus curiae of Intellectual Property Owners Association filed.

Brief amicus curiae of American Intellectual Property Law Association filed.

Blanket Consent filed by Respondents, Teva Pharmaceuticals USA, Inc., et al..

Blanket Consent filed by Petitioner, Helsinn Healthcare S.A..

Motion to extend the time to file a response is granted in part and the time is extended to and including May 11, 2018.

Motion to extend the time to file a response from April 2, 2018 to May 17, 2018, submitted to The Clerk.

Petition for a writ of certiorari filed. (Response due April 2, 2018)

Parties

Helsinn Healthcare S.A., Petitioner, represented by Kannon K. Shanmugam

Teva Pharmaceuticals USA, Inc., et al., Respondent, represented by Steffen Nathanael Johnson

Amici Curiae

45 Intellectual Property Professors, Amicus Curiae, represented by Mark A. Lemley

Austin Intellectual Property Law Association, Amicus Curiae, represented by Stephen Roger Dartt

Bar Association of the District of Columbia, Amicus Curiae, represented by William F. Lawrence

Bar Association of the District of Columbia, Amicus Curiae, represented by Jonathan Alan Herstoff

Boston Patent Law Association, Amicus Curiae, represented by Ronald Edmund Cahill

Congressman Lamar Smith, Amicus Curiae, represented by Robert A. Armitage

Houston Intellectual Property Law Association, Amicus Curiae, represented by Iftikhar Ahmed

Pharmaceutical Research and Manufacturers of America, Amicus Curiae, represented by Scott Ethan Kamholz

The Biotechnology Innovation Organization (BIO), Amicus Curiae, represented by Alice O. Martin

THE INTELLECTUAL PROPERTY LAW ASSOCIATION OF CHICAGO, Amicus Curiae, represented by Charles W. Shifley

The Massachusetts Biotechnology Council, Amicus Curiae, represented by Sophie Feifei Wang

The Naples Roundtable, Amicus Curiae, represented by Matthew James Dowd

United States of America, Amicus Curiae, represented by Noel J. Francisco

US Inventor, Inc., Amicus Curiae, represented by Kathleen B. Carr

 
Last updated: November 21, 2024